Shaoying Li

8.2k total citations
210 papers, 3.4k citations indexed

About

Shaoying Li is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Shaoying Li has authored 210 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Pathology and Forensic Medicine, 82 papers in Genetics and 70 papers in Oncology. Recurrent topics in Shaoying Li's work include Lymphoma Diagnosis and Treatment (99 papers), Chronic Lymphocytic Leukemia Research (62 papers) and Viral-associated cancers and disorders (38 papers). Shaoying Li is often cited by papers focused on Lymphoma Diagnosis and Treatment (99 papers), Chronic Lymphocytic Leukemia Research (62 papers) and Viral-associated cancers and disorders (38 papers). Shaoying Li collaborates with scholars based in United States, China and Canada. Shaoying Li's co-authors include L. Jeffrey Medeiros, C. Cameron Yin, Pei Lin, Guilin Tang, Roberto N. Miranda, Joseph D. Khoury, Jie Xu, Shimin Hu, Sa A. Wang and Wei Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Shaoying Li

198 papers receiving 3.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shaoying Li 1.7k 1.3k 1.0k 731 476 210 3.4k
Antoine Martin 872 0.5× 748 0.6× 515 0.5× 403 0.6× 300 0.6× 78 2.9k
Steven C. Ziesmer 1.2k 0.7× 1.2k 0.9× 716 0.7× 580 0.8× 274 0.6× 65 3.2k
Hélène Merle‐Béral 1.6k 1.0× 874 0.7× 1.6k 1.6× 1.1k 1.5× 434 0.9× 157 4.3k
Nicolás Ortonne 1.4k 0.8× 702 0.5× 329 0.3× 807 1.1× 231 0.5× 203 4.8k
Yasuo Sugita 1.3k 0.8× 1.2k 0.9× 912 0.9× 585 0.8× 63 0.1× 171 3.2k
Anand S. Lagoo 579 0.3× 766 0.6× 463 0.5× 951 1.3× 793 1.7× 70 2.8k
Yasufumi Masaki 707 0.4× 813 0.6× 382 0.4× 411 0.6× 266 0.6× 115 2.6k
Ji Eun Kim 635 0.4× 1.0k 0.8× 566 0.6× 955 1.3× 84 0.2× 137 3.1k
Yasuhito Hamaguchi 2.3k 1.3× 584 0.4× 451 0.4× 877 1.2× 246 0.5× 168 6.2k
Marco Gobbi 644 0.4× 1.3k 1.0× 896 0.9× 1.0k 1.4× 1.9k 4.0× 171 3.9k

Countries citing papers authored by Shaoying Li

Since Specialization
Citations

This map shows the geographic impact of Shaoying Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoying Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoying Li more than expected).

Fields of papers citing papers by Shaoying Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoying Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoying Li. The network helps show where Shaoying Li may publish in the future.

Co-authorship network of co-authors of Shaoying Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoying Li. A scholar is included among the top collaborators of Shaoying Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoying Li. Shaoying Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Qing, Shimin Hu, Sanam Loghavi, et al.. (2025). Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia. American Journal of Hematology. 100(3). 417–426. 6 indexed citations
2.
3.
Shuyu, E, Francisco Vega, Hong Fang, et al.. (2025). BCL11B helps to define T-lineage in lymphomas/leukaemias with a mixed/ambiguous immunophenotype. Pathology. 57(6). 746–752. 1 indexed citations
4.
Nahmod, Karen, Guilin Tang, Shaoying Li, Carlos A. Torres‐Cabala, & Jie Xu. (2024). Acquisition of TP63 Rearrangement in Large Cell Transformation of Mycosis Fungoides. SHILAP Revista de lepidopterología. 5(1). 264–265. 1 indexed citations
5.
Fang, Hong, Sa A. Wang, Hannah C. Beird, et al.. (2024). Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family–negative T-prolymphocytic leukemia. American Journal of Clinical Pathology. 162(6). 582–590. 1 indexed citations
6.
Loghavi, Sanam, Qing Wei, Farhad Ravandi, et al.. (2024). Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia. American Journal of Hematology. 99(10). 1959–1968. 17 indexed citations
7.
Wang, Sa A., Jeffrey L. Jorgensen, Shimin Hu, et al.. (2023). Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection. Cytometry Part B Clinical Cytometry. 104(5). 356–366. 10 indexed citations
8.
Li, Nianyi, Pei Lin, Zhuang Zuo, et al.. (2023). Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis. Cancer Medicine. 12(13). 14293–14304. 7 indexed citations
9.
Wang, Yanchao, et al.. (2022). Molecular Epidemiology and Hematologic Characterization of Thalassemia in Guangdong Province, Southern China. Clinical and Applied Thrombosis/Hemostasis. 28. 2985301311–2985301311. 19 indexed citations
11.
Qiu, Lianqun, L. Jeffrey Medeiros, Guilin Tang, et al.. (2021). The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis. Cancers. 13(24). 6316–6316. 5 indexed citations
12.
Sakhdari, Ali, Huan Mo, Do H. Kim, et al.. (2021). EZH2 expression is associated with inferior overall survival in mantle cell lymphoma. Modern Pathology. 34(12). 2183–2191. 8 indexed citations
13.
Jain, Preetesh, Rashmi Kanagal‐Shamanna, Shaojun Zhang, et al.. (2021). Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib. American Journal of Hematology. 96(5). E137–E140. 5 indexed citations
14.
Chitsazzadeh, Vida, Shaoying Li, Ken H. Young, et al.. (2021). Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma. International Journal of Gynecological Pathology. 40(3). 229–233. 2 indexed citations
15.
Lyapichev, Kirill A., Guilin Tang, Shaoying Li, et al.. (2020). MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma. Human Pathology. 108. 22–31. 10 indexed citations
16.
Jain, Preetesh, Guilin Tang, Shaoying Li, & Michael Wang. (2020). “Triple hit” SOX11, MME+, TP53 mutated high‐grade pleomorphic mantle cell lymphoma. American Journal of Hematology. 96(1). 165–166.
17.
Yabe, Mariko, L. Jeffrey Medeiros, Guilin Tang, et al.. (2015). Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. Human Pathology. 50. 109–117. 11 indexed citations
18.
Wang, Beinan, Shaoying Li, Peter J. Southern, & P. Patrick Cleary. (2006). Streptococcal modulation of cellular invasion via TGF-β1 signaling. Proceedings of the National Academy of Sciences. 103(7). 2380–2385. 45 indexed citations
19.
Li, Shaoying, Soichiro Sato, Xiaojing Yang, Patricia A. Preisig, & Robert J. Alpern. (2004). Pyk2 activation is integral to acid stimulation of sodium/hydrogen exchanger 3. Journal of Clinical Investigation. 114(12). 1782–1789. 75 indexed citations
20.
Liu, Wen-Yu, et al.. (1963). ON THE DIGESTION AND UTILIZATION OF SOME PLANTS BY FINGERLINGS OF THE GRASS CARP, CTENOPHARYNGODON IDELLUS (Cuv. & Val.). Acta Hydrobiologica Sinica. 4(3). 112–120. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026